| Article | Added |
|---|
| What Transparency Means for Healthcare | 05-09-13 |
| Spate of Life Science IPOs Ready to Debut | 05-07-13 |
| Healthcare Spending Projections May Be Overstated by $770B | 05-07-13 |
| Celgene Strikes A Deal with Concert | 05-07-13 |
| The May 2013 Issue of The Burrill Report | 05-03-13 |
| Regulus CEO Praises JOBS Act | 05-03-13 |
| New Hormone Holds Promise for Diabetics | 05-03-13 |
| Natera Lands $54.6 Million to Tranform Pre-Natal Testing | 05-03-13 |
| Atlas Ventures Closes $265 Million Fund | 05-03-13 |
| Merck and Pfizer Collaborate on Diabetes Drug | 05-03-13 |
| Capital Royalty Raises $805 Million Fund | 05-03-13 |
| Aveo and Astellas Trial Fails to Impress Advisory Panel | 05-03-13 |
| European Court Enjoins EMA from Releasing AbbVie, InterMune Data | 05-03-13 |
| Ambrx Strikes Deal with Bristol-Myers for ADC Technology | 05-03-13 |
| Why Gene Therapy Is Coming of Age | 05-02-13 |
| Doctors Worldwide Call for Lower Cancer Drug Prices | 04-25-13 |
| GSK Teams with Avalon to Fund San Diego Biotechs | 04-26-13 |
| Ocera Therapeutics Going Public in Merger with Tranzyme | 04-26-13 |
| Vaccine Makers Face Global Challenges | 04-26-13 |
| Novartis Faces Federal Claims of Kickbacks in Civil Court | 04-26-13 |
| Theravance Splitting in Two | 04-26-13 |
| Global Biotech Survey Highlights Romania, United Arab Emirates | 04-26-13 |
| AstraZeneca Makes a String of Early-Stage Deals | 04-26-13 |
| AstraZeneca Makes String of Early-Stage Deals | 04-24-13 |
| Bill Introduced to Require Labeling of Genetically Engineered Foods | 04-26-13 |
| Why Biotechs Need to Adapt to the Value-Based World | 04-23-13 |
| Incentives Reward Surgical Complications | 04-19-13 |
| Allecra Debuts with $19.5 Million in Funding | 04-19-13 |
| FDA Won?t Approve Generic Oxycontin | 04-19-13 |
| Supreme Court Hears Oral Arguments in Myriad case | 04-19-13 |
| Royalty Pharma Moves to Acquire Elan | 04-19-13 |
| Celltrion Drops Late-Stage Trial of Roche Rituxan Drug Copy | 04-18-13 |
| Thermo Fisher Acquires Life Tech for $13.6B | 04-19-13 |
| U.S. Regulators Lag European Counterparts in Protecting Patients, Report Says | 04-18-13 |
| Back to that Same Old Place | 04-18-13 |
| Chimerix and Omthera Go Public in Upsized Offerings | 04-12-13 |
| Lilly Seeks Savings in Salesforce Cuts | 04-10-13 |
| GSK Offers $1 Million Prize for Brain Breakthroughs | 04-11-13 |
| Precision Medicine Meets Antibiotics | 04-11-13 |
| Seeking Drug Savings, But Risking Safety | 04-11-13 |
| Obama Budget Raises Ire of PhRMA, BIO | 04-11-13 |
| Practice Makes Perfect | 04-10-13 |
| GSK Trial Shows Encouraging Results for Duchenne MD | 04-10-13 |
| Inovio and U.S. Army Receive $3.5 Million Biodefense Grant | 04-10-13 |
| VistaGen Secures $36 Million | 04-10-13 |
| CDC, BARDA Enlist Venter Institute to Combat H7N9 | 04-10-13 |
| Gene Mutation Could Direct Prostate Cancer Care | 04-10-13 |
| GSK Strikes Emerging Markets Deal with A*STAR | 04-09-13 |
| Gene Therapy Startup Raises $41 Million | 04-08-13 |
| Roche and Isis in $392M Antisense deal for Huntington's Disease | 04-08-13 |
| Bristol-Myers Replacing R&D Chief | 04-08-13 |
| Tumor Resistance Genes Can Be Detected Early | 04-08-13 |
| Appeals Court Rules Against Pfizer in Neurontin Case | 04-05-13 |
| Teva and Lonza Review Biosimilars Joint Venture | 04-05-13 |
| Scientists Find New Application for Cholesterol Drug | 04-05-13 |
| Exits Scarce for Venture Backed Companies in Q1 | 04-05-13 |
| NICE Branches into Social Care Standards | 04-05-13 |
| U.S. Trade Representative Reviewing India's Denial of Glivec Patent | 04-05-13 |
| Astellas Enters into $300M Cancer Collaboration with Ambrx | 04-04-13 |
| NIH Launches Brain Research Initiative | 04-04-13 |
| The JOBS Act One Year Later | 04-04-13 |
| Gleevec Ruling Is a Blow to Global Public Health | 04-02-13 |
| Health Insurers Seeking More for Their Dollars | 03-29-13 |
| Hundreds of clinical trials abandoned after CRO files for bankruptcy | 03-29-13 |
| Third Rock Ventures Raises $516 Million for New Biotech Fund | 03-29-13 |
| Edison Pharma Signs $545M Deal with Dainippon Sumitomo | 03-29-13 |
| Medical Residents Can?t Win | 03-29-13 |
| Ziopharm Shares Tank on Trial Failure | 03-29-13 |
| Expanding Research on Highly Toxic Agents Concerns Government Accounting Office | 03-28-13 |
| Lundbeck Enters Potential $825 Million Deal for Alzheimer's Drug | 03-29-13 |
| The April 2013 Issue of The Burrill Report | 03-28-13 |
| SCOTUS Weighs Pay-for-Delay | 03-28-13 |
| RARE Webinar: Understanding Drug Development | 03-25-13 |
| Two Life Sciences IPOs Debut | 03-22-13 |
| President Obama Outlines $2B Energy Security Trust | 03-22-13 |
| Feds Ponder Role of Kids in Biodefense Trials | 03-22-13 |
| One in Three U.S. Seniors Die with Dementia | 03-22-13 |
| Spanish Researchers Identify Key Mutation in CLL | 03-22-13 |
| AstraZeneca Slashes R&D, Sales Jobs in Consolidation | 03-22-13 |
| Sanofi and Biogen get EU Nod on MS Drugs | 03-22-13 |
| Affymax Eliminates 75 Percent of Staff, Considers Sale or Bankruptcy | 03-22-13 |
| Wyden Open Spaces | 03-22-13 |
| Will Regulation Dampen Digital Health Innovation | 03-21-13 |
| High Profile Pay Cuts Reflect Move to Pay-For Performance | 03-15-13 |
| Initiative Expanded to Advance Translational Research | 03-15-13 |
| U.K. Regulator Finds Man Guilty of Falsifying Preclinical Data | 03-15-13 |
| FDA Proposes to Lower Bar for New Alzheimer's Drugs | 03-15-13 |
| Application of Nanoparticles Moves From Lab to Field | 03-15-13 |
| Shire Acquires Premacure | 03-14-13 |
| Drug Companies Sue EMA over Trials Data | 03-15-13 |
| PhRMA Cheers Progress in Biotech | 03-15-13 |
| Why VC Investment in Emerging Markets Is a Demand Problem | 03-14-13 |
| The March 2013 Issue of The Burrill Report | 03-12-13 |
| Jury Orders J&J to Pay Plaintiff $8.3 Million for Defective Hip Implant | 03-08-13 |
| Study Finds Potential Risk in EHR Adoption | 03-08-13 |
| Device Tax Concerns Expand to Smartphones | 03-08-13 |
| Basis Science Raises $11.5 M for Health-Tracking Wristwatch | 03-08-13 |
| China to Reform Food and Drug Safety Oversight | 03-08-13 |
| New Initiative Takes on Multiple Sclerosis with Big Data | 03-08-13 |
| U.S. Spending on Traditional Prescription Drugs Fell in 2012 | 03-08-13 |
| Aggressive Treatment Halts HIV Infection in Newborn | 03-08-13 |
| A Proof-of-Concept for Fast Exit Strategy | 03-08-13 |
| Mylan to Pay $1.6 Billion for Strides Injectables Business | 03-01-13 |
| Royalty Pharma Offers to Acquire Elan for $6.55 Billion | 03-01-13 |
| FDA Approves New Breast Cancer Therapy | 03-01-13 |
| Mylan to Pay $1.6 Billion for Strides Arcolab's Injectables Business | 03-01-13 |
| Affymax and Takeda Recall Anemia Drug After Three Patients Died | 03-01-13 |
| Research Advocates Sound Alarm on NIH Sequestration Hit | 03-01-13 |
| India Weighs Price Controls versus Compulsory Licensing | 03-01-13 |
| Practice Fusion Buys Startup App Developer | 03-01-13 |
| OECD Calls for Harmonized Governance of Clinical Trials | 03-01-13 |
| Supreme Court Hears Monsanto Patent Case | 02-28-13 |
| Personal Information May Be Released from U.K. Sequencing Effort | 02-22-13 |
| Supreme Court Hears Monsanto Seed Case | 02-22-13 |
| Merck and Samsung Bioepis to Develop Biosimilars Together | 02-22-13 |
| Roche and Chiasma Collaborate on Rare Disease Drug | 02-22-13 |
| New $3 Million Breakthrough Prize Seeks to Elevate Scientists | 02-22-13 |
| Lab-grown Ear Matches the Real Thing | 02-22-13 |
| New U.K. Grant Program Taps Wisdom of Crowds | 02-21-13 |
| Fox Chase Partners to Personalize Cancer Care | 02-21-13 |
| Forever Young | 02-21-13 |
| Cardinal Health to Buy AssuraMed for $2 Billion | 02-15-13 |
| U.S. Government Recovers Record $4.2 Billion Lost to Fraud | 02-15-13 |
| The Computer Will See You Now | 02-15-13 |
| Speedy Approval May Await Breakthrough Therapies | 02-15-13 |
| Teva Faces $2.1 Billion in Damages For Jumping Gun on Protonix | 02-15-13 |
| IOM Calls for Reckoning on Cancer Costs | 02-15-13 |
| Industry Braces for Sequestration | 02-15-13 |
| BMS Licenses Over-the-Counter Brands to Reckitt for Latin America | 02-15-13 |
| StemCells Reports Encouraging Trial Results | 02-15-13 |
| Disruptive Delivery | 02-15-13 |
| Public-Private Partnership to Spur EU Innovation | 02-08-13 |
| Proteomics Research Gets a Boost | 02-08-13 |
| GSK Plans European Cuts | 02-08-13 |
| EU Drugmakers Enter Public-Private Partnership to Spur Innovation | 02-08-13 |
| Protalix Biotherapeutics, an Acquisition Target, Retains Citigroup | 02-08-13 |
| FDA Upgrades Ventilator Recall | 02-08-13 |
| The Medicines Company Acquires Rights to Alnylam Cholesterol Drug | 02-08-13 |
| Biogen Buys Tysabri Rights for $3.25 Billion | 02-08-13 |
| Senators Reignite Fight to Block Pay-for-Delay | 02-08-13 |
| Early Communications Fueling Success at FDA | 02-08-13 |
| Pharma's Growing Talent Gap | 02-08-13 |
| Europe to Invest $1.4 Billion To Create Detailed Brain Model | 02-01-13 |
| Ben Venue Laboratories Ordered to Stop Operations | 02-01-13 |
| The Lean Biotech Startup | 02-01-13 |
| Partnerships Moves Canadian Innovation Forward | 01-31-13 |
| Trial Results Boost Keryx | 01-31-13 |
| The February 2013 Issue of The Burrill Report | 02-01-13 |
| Zoetis IPO Raises $2.24 Billion | 02-01-13 |
| GlaxoSmithKine to Create New Vaccine with Indian Partner | 02-01-13 |
| Takeda Wins Diabetes Approvals | 02-01-13 |
| Seeking a New Approach to Migraines | 02-01-13 |
| LipoScience Raises $45 Million in IPO | 01-25-13 |
| Allegan to Buy MAP Pharmaceuticals for Nearly $1 billion | 01-25-13 |
| Translational Research Goes Global | 01-24-13 |
| Novartis Under Investigation on Multiple Fronts | 01-24-13 |
| Reviews Measure Impact of Mobile Health Tech | 01-24-13 |
| Smartphones Not Smart in Catching Melanomas | 01-24-13 |
| Brazil Places $294 Million Bet on Next-Gen Biofuels | 01-25-13 |
| California's Stem Cell Agency Seeks to Quell Criticism on Conflicts | 01-25-13 |
| Deep Brain Stimulation Trial Gets Underway | 01-25-13 |
| Repairing What's Broken | 01-24-13 |
| AstraZeneca and Vanderbilt Collaborate on Brain Disorders | 01-18-13 |
| Big Pharma's Reputation Sinks with Patient Groups | 01-18-13 |
| FDA Green-lights Neuralstem Trial | 01-18-13 |
| BMS Moves to Wrap Up Litigation Over Failed Trial | 01-18-13 |
| Court Ruling Creates Liability for Branded Drugmakers | 01-18-13 |
| Facing an Adherence and Compliance Gap | 01-17-13 |
| U.S. Public Biotechs Raise $1.2 Billion in Equity and Debt | 01-18-13 |
| Generic HIV Treatment Could Save $1 Billion Annually | 01-18-13 |
| Boosting Venture Capital in Canada | 01-18-13 |
| Optum Labs Research Center Open for Business | 01-18-13 |
| Just What the Doctor Ordered | 01-17-13 |
| Illumina Acquires Verinata for $450 Million | 01-11-13 |
| Cancer Deaths and Rates in the U.S. Continue to Decline | 01-11-13 |
| MacroGenics Signs Potential $1 Billion Deal with Gilead Sciences | 01-11-13 |
| FCC Lines Up $400 Million Annually for Telehealth | 01-11-13 |
| Agbiotech Startup Gets Funding | 01-11-13 |
| Flu Bug Putting Strain on Tamiflu Supply | 01-11-13 |
| BioTime Picks Up Geron's Stem Cell Assets | 01-11-13 |
| FDA Awards Vertex Breakthrough Designations | 01-11-13 |
| Tufts Sees Promise in Open Innovation | 01-11-13 |
| California's Biomedical Industry Shows Resilience | 01-11-13 |
| Sarepta Adored While Anthera Suffers | 01-04-13 |
| IPOs Keep Pace | 01-03-13 |
| San Francisco Adds Three Biotech Startups in New Year | 01-03-13 |
| Life Sciences Companies Raise $92.5 Billion in Financings in 2012 | 01-04-13 |
| A Banner Year for New Drugs | 01-04-13 |
| Life Sciences M&A Sees Fewer Billion Dollar Deals | 01-04-13 |
| Discovery and Research Deals Lead Partnering | 01-04-13 |
| Biogen's ALS Drug Fails Late-Stage Trial | 01-03-13 |
| Regenerating Excitement | 01-04-13 |
| Ode to Healthcare in 2013 | 01-03-13 |
| Biotech Visionary G. Steven Burrill Offers Predictions for 2013 | 12-28-12 |
| Taking Stock: 2012, the JPMorgan Healthcare Conferece, and Beyond | 12-28-12 |
| Sutro Biopharma Enters into $500M Deal with Celgene | 12-21-12 |
| Amgen Settles Biggest Ever Biotech Off-Label Case | 12-21-12 |
| Tapping Diverse Pools of Capital | 12-21-12 |
| Sanofi Lays Foundation for new Industrial Facility in Saudi Arabia | 12-21-12 |
| The January 2013 Issue of The Burrill Report | 12-21-12 |
| FDA Guides Industry on How to Tailor Trials | 12-20-12 |
| Research Spending Creeps Upward | 12-21-12 |
| Blindness in Type 2 Diabetes Patients Might Be Preventable | 12-21-12 |
| Biogen Enlists Cell Biologists to Unlock ALS | 12-21-12 |
| Removing IP Barriers to Innovation | 12-20-12 |
| Podcast Series: The Virtual Scientific Workplace | 12-13-12 |
| National Health Service to Map DNA of Up to 100,000 Patients | 12-14-12 |
| Amgen to Acquire deCODE Genetics for $415 Million | 12-13-12 |
| EU Leaders Agree on Patent Package | 12-13-12 |
| FDA Approves Ariad's Cancer Drug Iclusig | 12-14-12 |
| Gilead to Buy YM BioSciences for $510 Million | 12-14-12 |
| Teva Looks for $2 Billion in Savings | 12-13-12 |
| India's Patent Office Revocations Continue | 12-13-12 |
| Measuring Returns from Innovation | 12-13-12 |
| The Virtual Scientific Workplace | 12-07-12 |
| ?Pay-for-Delay? Goes to U.S. Supreme Court | 12-13-12 |
| Antisense Gets Respect | 12-13-12 |
| Geron Favors Telomerase Target over Blood-Brain-Barrier in Company Restructuring | 12-07-12 |
| Baxter to Acquire Gambro for $4 Billion | 12-07-12 |
| Drugmakers and Academia Unite to Create iPS Stem Cell Bank | 12-07-12 |
| New Estimate of Drug Development Costs Pegs Total at $1.5 Billion | 12-07-12 |
| $700,000 in Gold Dust Goes Missing from Pfizer Lab | 12-06-12 |
| Congressman Sees Jobs in Health Tech Boom | 12-06-12 |
| AliveCor Launches iPhone Heart Monitor | 12-07-12 |
| Device Makers Partner with FDA to Speed Reviews | 12-07-12 |
| FDA Touts Its Record on Approvals | 12-07-12 |
| 2020: The New World of Work | 12-04-12 |
| GSK Announces $1Billion Expansion in Emerging Market Nutritionals | 11-30-12 |
| Smith & Nephew Makes $782 Million Push into Wound Care | 11-30-12 |
| Collaboration Critical to Address Global Health Challenges | 11-30-12 |
| Roche and the Broad Institute Collaborate to Find New Uses for Abandoned Compounds | 11-30-12 |
| Selecta Biosciences Strikes Vaccine Partnership with Sanofi | 11-30-12 |
| Drugmakers Go Prospecting in Québec | 11-30-12 |
| Branded Drug Prices Rise Sharply in U.S. | 11-30-12 |
| Novartis Threatens to Pull R&D from the U.K. | 11-29-12 |
| Big Pharma Expands Access to Medicines | 11-30-12 |
| Fiscal Cliff Threatens Life Sciences Industry | 11-29-12 |
| Stem Cells Ready for Prime Time in Drug Discovery | 11-29-12 |
| Questioning Values | 11-21-12 |
| Tiny Bio-bots Show Promise | 11-21-12 |
| Regular Check-Ups Fail to Extend Life | 11-21-12 |
| TauRx Lands $112 Million to Fund Alzheimer's Trial | 11-21-12 |
| Diabetes Cases Soar in the United States | 11-21-12 |
| Teams Seek Answers in Genomic Data | 11-21-12 |
| AMA Builds Out Policy Agenda at Meeting | 11-21-12 |
| Startup Will Map Funders' Microbiomes | 11-21-12 |
| Fund Manager Targeted for Insider Trades | 11-21-12 |
| The December 2012 Issue of The Burrill Report | 11-21-12 |
| Progress Slow in Combating Fake Drugs | 11-20-12 |
| No Longer a Working Experiment | 11-20-12 |
| Compounding Crisis Highlights Gaps in FDA Jurisdiction | 11-16-12 |
| Mirror, Mirror | 11-16-12 |
| Intarcia Raises $210 Million to Fund Late Stage Trial | 11-16-12 |
| Researcher Calls for Roche Boycott | 11-16-12 |
| FDA Achieves Small Win as Whistleblower Law Passed | 11-15-12 |
| QB3's Grandest Experiment Pays Off | 11-13-12 |
| Roche Seeks Insurance Policy for the Chinese Market | 11-13-12 |
| Roche Seeks Insurance Policy for the Chinese Market | 11-13-12 |
| Intarcia Raises $210 Million to Fund Late Stage Trial | 11-16-12 |
| Researcher Calls for Roche Boycott | 11-16-12 |
| FDA Achieves Small Win as Whistleblower Law Passed | 11-15-12 |
| QB3's Grandest Experiment Pays Off | 11-13-12 |
| Progress Slow in Combating Fake Drugs | 11-20-12 |
| No Longer a Working Experiment | 11-20-12 |
| Compounding Crisis Highlights Gaps in FDA Jurisdiction | 11-16-12 |
| Mirror, Mirror | 11-16-12 |
| AMA Builds Out Policy Agenda at Meeting | 11-21-12 |
| Startup Will Map Funders' Microbiomes | 11-21-12 |
| Fund Manager Targeted for Insider Trades | 11-21-12 |
| The December 2012 Issue of The Burrill Report | 11-21-12 |
| Regular Check-Ups Fail to Extend Life | 11-21-12 |
| TauRx Lands $112 Million to Fund Alzheimer's Trial | 11-21-12 |
| Diabetes Cases Soar in the United States | 11-21-12 |
| Teams Seek Answers in Genomic Data | 11-21-12 |
| Stem Cells Ready for Prime Time in Drug Discovery | 11-29-12 |
| Questioning Values | 11-21-12 |
| Tiny Bio-bots Show Promise | 11-21-12 |
| Researcher Calls for Roche Boycott | 11-16-12 |
| FDA Achieves Small Win as Whistleblower Law Passed | 11-15-12 |
| QB3's Grandest Experiment Pays Off | 11-13-12 |
| Roche Seeks Insurance Policy for the Chinese Market | 11-13-12 |
| Progress Slow in Combating Fake Drugs | 11-20-12 |
| No Longer a Working Experiment | 11-20-12 |
| Compounding Crisis Highlights Gaps in FDA Jurisdiction | 11-16-12 |
| Mirror, Mirror | 11-16-12 |
| Intarcia Raises $210 Million to Fund Late Stage Trial | 11-16-12 |
| AMA Builds Out Policy Agenda at Meeting | 11-21-12 |
| Startup Will Map Funders' Microbiomes | 11-21-12 |
| Fund Manager Targeted for Insider Trades | 11-21-12 |
| The December 2012 Issue of The Burrill Report | 11-21-12 |
| Tiny Bio-bots Show Promise | 11-21-12 |
| Regular Check-Ups Fail to Extend Life | 11-21-12 |
| TauRx Lands $112 Million to Fund Alzheimer's Trial | 11-21-12 |
| Diabetes Cases Soar in the United States | 11-21-12 |
| Teams Seek Answers in Genomic Data | 11-21-12 |
| Stem Cells Ready for Prime Time in Drug Discovery | 11-29-12 |
| Questioning Values | 11-21-12 |
| Outlook for Small Biotech Remains Difficult | 10-12-12 |
| Two Biotech IPOs Raise $145 million | 10-12-12 |
| OVP Venture Partners Calling It Quits | 10-12-12 |
| Johnson & Johnson Seeks a Secure Line to Patients | 10-12-12 |
| Scripps Creates Digital Medicine Program with Qualcomm | 10-12-12 |
| India and China Heighten Scrutiny of Medical Devices | 10-12-12 |
| Commission Calls for Genome Privacy Protections | 10-12-12 |
| UnitedHealth Group to Acquire Brazil's Largest Health Insurer | 10-11-12 |
| Lilly, Roche Drugs Chosen for Alzheimer's Trial | 10-12-12 |
| Presidential Ccommission Calls for Whole Genome Sequencing Privacy Protections | 10-12-12 |
| Open Science and Reinventing Discovery | 10-11-12 |
| Regulus IPO: Slash Price, Offer More Shares | 10-04-12 |
| FDA Says Teva Generic Antidepressant Falls Short | 10-05-12 |
| UPMC Promotes Personalized Medicine with Big Data Initiative | 10-04-12 |
| Breast Cancer Study Points to Personalized Treatments | 10-05-12 |
| J&J Snags Rights to Astellas Drug for up to $945 Million | 10-05-12 |
| Medtech Ready to Outshine Pharma | 10-05-12 |
| FDA Defibrillator Approval Triggers Payday | 10-04-12 |
| NantWorks Delivers High-Speed Genomics Platform | 10-04-12 |
| Roche's T-DM1 Shines in Breast Cancer Trial | 10-04-12 |
| Economist Pitches Megafund to Fight Cancer | 10-04-12 |
| Sanofi Cuts Staff in R&D Reshuffle | 09-28-12 |
| Medtronic Agrees to Pay $816M for China Kanghui Holdings | 09-28-12 |
| Drugmakers Paid Feds and States $6.6 Billion in First Half of 2012 | 09-28-12 |
| Presidential Science Advisor Plan Seeks to Double New Drug Approvals | 09-28-12 |
| FDA Gets New Authority over Trials Data | 09-28-12 |
| FDA Launches Antibacterial Drugs Task Force | 09-28-12 |
| Peregrine Shares Plunge on Data Discrepancies | 09-28-12 |
| Aetna Enlists GNS Healthcare in Metabolic Syndrome Fight | 09-28-12 |
| MD Anderson Launches $3 Billion Moon Shots Program Against Cancer | 09-27-12 |
| Syngenta Pushes into Biologic Pest Control | 09-20-12 |
| The October 2012 Issue of The Burrill Report | 09-21-12 |
| Threshold Pharmaceuticals? Cancer Drug Misses Target | 09-20-12 |
| Johnson & Johnson Plans New Global Innovation Centers | 09-20-12 |
| Drugmakers Band Together on Challenges | 09-21-12 |
| Life Technologies to Make Companion Diagnostics for Bristol-Myers Squibb | 09-21-12 |
| Vivus Launches U.S. Sales of Obesity Drug | 09-21-12 |
| Will Biotech Double Life Expectancy? | 09-18-12 |
| China to Mandate Lower Prices on Select Drugs | 09-20-12 |
| BGI-Shenzhen to Acquire Complete Genomics for $117.6M | 09-20-12 |
| MedImmune and WuXi Team Up | 09-14-12 |
| Drug Pipelines Show Waning Progress, Analysis Says | 09-14-12 |
| J&J Terminates Trial of Investigational Skin Disorder Drug | 09-14-12 |
| Venture Financings on the Rebound | 09-14-12 |
| Tobira Therapeutics Completes Senior Management Team | 09-14-12 |
| Illumina and Partners Healthcare Ally to Help Docs Interpret Genetic Data | 09-13-12 |
| Indian High Court Upholds Right to Copy Roche Drug | 09-14-12 |
| AstraZeneca Strikes Partnership with Broad Institute | 09-14-12 |
| Geron's Course Correction Hits Rocky Road | 09-14-12 |
| Opexa's Personalized MS Immunotherapy Returns to Clinic | 09-15-12 |
| Industry Group Turns to Crowdfunding for Biotech Startups | 09-06-12 |
| ENCODE Decodes Junk DNA | 09-07-12 |
| Symphogen Licenses Lead Cancer Drug to Merck KGaA | 09-07-12 |
| Drugmakers Jockey to Lead Prostate Cancer Market | 09-07-12 |
| Eli Lilly Suffers another Late-Stage Drug Failure | 09-07-12 |
| IOM Slams Waste and Dysfunction in U.S. Healthcare | 09-07-12 |
| India Expanding Drug Price Controls | 09-07-12 |
| Valeant to Acquire Medicis for $2.6 Billion | 09-07-12 |
| BioMotiv Aims to Accelerate Therapeutic Innovation | 09-07-12 |
| Creating Personalized Medicine Bit by Bit | 09-07-12 |
| Genmab Scores in $1.1 Billion Licensing Deal with J&J | 08-31-12 |
| Protecting Sustainable Innovation | 08-31-12 |
| AstraZeneca Appoints New CEO | 08-30-12 |
| Roche Cancer Drug Meets Primary Trial Endpoint | 08-30-12 |
| FDA Halts Idenix's Second Hepatitis C Drug | 08-31-12 |
| HHS Finalizes New Electronic Health Records Rule | 08-31-12 |
| Federal Funding of Stem Cell Research Stands | 08-31-12 |
| FDA Approves Gilead's 4-in-1 HIV Pill | 08-30-12 |
| Delaying Tumors | 08-31-12 |
| Alnylam Plants Its RNAi Technology with Monsanto | 08-30-12 |
| China Set to Increase Number of Drugs Subject to Price Controls | 08-23-12 |
| BMS Backs out of Crowded Hepatitis C Race | 08-24-12 |
| China Clones Two GM Calves | 08-23-12 |
| Partnering for Health | 08-24-12 |
| Allergan and Molecular Partners Enter $1.4 Billion Alliance | 08-24-12 |
| Stanford Teams with Intel on Diagnostics | 08-24-12 |
| Sanofi Pulls Campath to Protect Value of New MS Drug | 08-24-12 |
| NICE Appeals Process Overhaul in the Works | 08-24-12 |
| Trial Seeks to Use Stem Cells to Treat Autism | 08-24-12 |
| Feeling Love for Orphans | 08-24-12 |
| The September 2012 Issue of The Burrill Report | 08-22-12 |
| The September 2012 Issue of The Burrill Report | 08-22-12 |
| Elan to Shed Drug Discovery Unit | 08-16-12 |
| RNA Therapeutics in the Dealmaking Spotlight | 08-16-12 |
| Pfizer's Animal Health Unit Zoetis Files IPO | 08-17-12 |
| Inching Closer to a Pill for Men | 08-17-12 |
| Whistleblower Sues Genentech | 08-16-12 |
| Tengion Fights to Survive | 08-16-12 |
| Putting Academic Research to the Test | 08-17-12 |
| Myriad Appeal Is DeJa Vu All Over Again | 08-17-12 |
| PatientsLikeMe Collaborates with Merck | 08-17-12 |
| Idenix Hep C Drug Put on Hold over Safety Concerns | 08-17-12 |
| PatientsLikeMe Forms Health Data Collaboration with Merck | 08-17-12 |
| Innovation Bank Proposed | 08-09-12 |
| China Invests in U.K. Diagnostics Startup | 08-09-12 |
| Alzheimer's Drug Bapineuzumab Fails in Second Trial | 08-09-12 |
| Nanobiotix teams up with PharmaEngine in Nanomedicine Deal | 08-10-12 |
| Pharma Heads Back to School | 08-09-12 |
| Personalizing Pain Medications | 08-09-12 |
| As Drugmakers Turn to Global Trials, Politicians Seek Greater Transparency | 08-09-12 |
| Targeted Drugs Show Less Serious Side Effects | 08-09-12 |
| Novartis and UPenn Strike Strategic Partnership | 08-09-12 |
| U.K. Drug Pricing Talks Approach | 08-09-12 |
| Bioethics Commission Readies Privacy Advice | 08-02-12 |
| Customized Therapy | 08-03-12 |
| Biorenewables Companies Make Headway | 08-02-12 |
| Globus Medical Prices IPO at $12 per Share | 08-03-12 |
| Bristol-Myers Bet on Hepatitis C Drug Takes Major Hit | 08-01-12 |
| Roche CEO Bullish on China | 08-01-12 |
| Regulate Me | 08-02-12 |
| Proteus Gains FDA Clearance for Ingestible Sensor | 08-02-12 |
| Generics Saved $1 Trillion over Past 10 Years | 08-02-12 |
| Dendreon Cuts Jobs as It Battles Weak Sales | 08-02-12 |
| India Preparing to Introduce Price Controls | 07-27-12 |
| Amarin Wins FDA Approval of Vascepa | 07-27-12 |
| Hyperion Therapeutics Goes Public | 07-27-12 |
| Supreme Court Ruling on Healthcare Reform Will Lower Costs | 07-27-12 |
| California's Stem Cell Agency Approves $150 Million Grants | 07-27-12 |
| NIH and DARPA Fund Development of Organ-on-a-Chip Systems | 07-27-12 |
| Fresenius Kabi Plans to Acquire Fenwal | 07-26-12 |
| NIH and DARPA Fund Development of Tissue Chips for Drug Screening | 07-27-12 |
| Amarin Announces FDA Approval of Vascepa | 07-27-12 |
| Blackstone invests $125 Million in NantPharma | 07-27-12 |
| NEA Reveals $2.6 Billion Global Venture Fund | 07-27-12 |
| Building a Better Cancer Drug | 07-27-12 |
| Alzheimer's Drug Fails Late-Stage Trial | 07-26-12 |
| The August 2012 Issue of The Burrill Report | 07-24-12 |
| Tools Companies Expand in Diagnostics | 07-20-12 |
| FDA approves Onyx Multiple Myeloma Drug | 07-20-12 |
| First Gene Therapy Gets EU Backing | 07-20-12 |
| MedImmune to Cut 200 Jobs in California | 07-20-12 |
| Confidence Shaken | 07-20-12 |
| Durata Therapeutics Becomes Second Completed IPO in Month | 07-20-12 |
| Human Genome Sciences and GlaxoSmithKline End Hostilities | 07-19-12 |
| Senator Turns Heat Up on FDA in Spying Scandal | 07-18-12 |
| Vivus? Obesity Drug Gains FDA Approval | 07-18-12 |
| Senator Says FDA Spying on Whistleblowers was Authorized | 07-18-12 |
| AstraZeneca Ramping up Virtual Neuroscience Effort | 07-13-12 |
| Chelsea Therapeutics' CEO Steps Down | 07-13-12 |
| Clinical Trials Waste Billions of Dollars Through Unnecessary Procedures | 07-13-12 |
| 23andMe Acquires CureTogether | 07-13-12 |
| The Already-Approved Drug Researchers Think Can Combat Aging | 07-12-12 |
| Biolex Files for Bankruptcy | 07-12-12 |
| Complete Genomics Says Tech Sets Standard for Clinical Grade Genomes | 07-12-12 |
| Janssen and Evotec Partner on Portfolio of Diabetes Drugs | 07-12-12 |
| Obama Signs User Fee Bill | 07-10-12 |
| Cells From Parkinson's Patients Show Unique Drug Responses | 07-06-12 |
| GSK to Pay $3 Billion to Settle Civil and Criminal Charges with U.S. and States | 07-06-12 |
| Pfizer Grants Russia's SatRx Rights to Diabetes Compound | 07-05-12 |
| BMS to Acquire Amylin for $5.3 Billion Plus Debt | 07-06-12 |
| Sanofi May Slash 2,000 Jobs in France | 07-06-12 |
| FDA proposes ID system for medical devices | 07-06-12 |
| USPTO Official Attacks Compulsory License | 07-06-12 |
| First Rapid Over-the-Counter HIV Test Approved in U.S. | 07-06-12 |
| NIH Targets $275M for Rare Disease Research | 07-06-12 |
| Rare Disease Community Scores a Big Victory | 07-06-12 |
| Idec and Isis Pharmaceuticals in Rare Disease Pact | 06-29-12 |
| New Mobile Healthcare Survey Reveals Mixed Bag | 06-29-12 |
| Making NICE with Investors | 06-29-12 |
| FDA Approves Arena's Obesity Drug | 06-29-12 |
| India Proposes Offering Generic Drugs for Free | 06-29-12 |
| Digital Health VC Financing Booms in Year's First Half | 06-29-12 |
| User Fee Bill Awaits President's Signature | 06-29-12 |
| Supreme Court Upholds Healthcare Reform | 06-29-12 |
| Roche to Shed 1,000 Jobs in New Jersey | 06-29-12 |
| Overhauling R&D with Nothing but Net | 06-29-12 |
| Celgene Withdraws EU Application for Revlimid | 06-22-12 |
| Celgene Withdraws EU Application for Revlimed | 06-22-12 |
| BGI and Hospital Plan to Sequence 1,000 Rare Diseases | 06-22-12 |
| BIO Study: Bayh-Dole Shows Big Returns | 06-22-12 |
| The Biotech Story You Won?t Read in your Local Newspaper | 06-22-12 |
| User Fee Bill Passes the House | 06-22-12 |
| India Unveils Plans for Reviewing Biosimilars | 06-22-12 |
| Alzheimer's Disease Fight Heats Up | 06-22-12 |
| Ambrx Lands $303M Deal to Make Improved Drugs | 06-22-12 |
| Drugmakers Pledge $1.8M to Advance Neuroscience Research | 06-23-12 |
| Seeing a Silver Lining to Big Pharma's Patent Cliff | 06-21-12 |
| The July 2012 Issue of The Burrill Report | 06-15-12 |
| Mapping the Single Cell World | 06-15-12 |
| A Gentleman's D for Mitt | 06-15-12 |
| Startups raise $786 million in June's First Half | 06-15-12 |
| A Drug by Any Other Name | 06-15-12 |
| BSN Medical Acquired by EQT in $2.5 Billion Deal | 06-15-12 |
| Computer Model Predicts Drug Side Effects | 06-15-12 |
| Children of Older Fathers May Live Longer Than Most | 06-15-12 |
| Johnson & Johnson Reaches $2.2 Billion Settlement with Government over Marketing Probes | 06-15-12 |
| Genentech's Big Bet on New Cancer Drugs | 06-15-12 |
| A Pitch to Employees | 06-14-12 |
| California Smoking Tax Vote Outcome Too Close to Call | 06-08-12 |
| D? Bomb | 06-08-12 |
| Astellas and Drais Partner to Launch Virtual Company | 06-08-12 |
| Dr. Reddy's and Merck Serono Partner on Biosimilars | 06-08-12 |
| Chelsea Execs Take Pay Cuts Amid Troubles | 06-08-12 |
| HHS and West Wireless Partner to Kickstart Health App Development | 06-08-12 |
| Why Dendreon May Have Felt Less Pain at ASCO than Expected | 06-07-12 |
| U.S. Third Worst among 12 Developed Countries for Value-Based Healthcare | 06-08-12 |
| Complete Genomics Restructures, Seeks Strategic Alternatives | 06-08-12 |
| Phone Appointments Effective in Battling Depression | 06-07-12 |
| Marina Biotech Slashes 90 Percent of Workforce | 05-31-12 |
| Bristol-Myers Squibb Forms the International Immuno-Oncology Network | 05-31-12 |
| 23andMe Patent Creates Concerns with Customers | 06-01-12 |
| China Poised to Boost Biotech | 06-01-12 |
| User Fee Packages Win Congressional Approval | 06-01-12 |
